|Bid||146.78 x 800|
|Ask||215.88 x 800|
|Day's Range||214.90 - 223.54|
|52 Week Range||158.01 - 236.51|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||57.00|
|Earnings Date||Feb 25, 2021 - Mar 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||228.67|
Most readers would already be aware that ICU Medical's (NASDAQ:ICUI) stock increased significantly by 12% over the past...
SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 39th Annual Healthcare Conference, held virtually January 11-14, 2021. ICU Medical’s presentation will be on Wednesday, January 13, 2021 at 8:40 a.m. PST (11:40 a.m. EST). The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.About ICU Medical, Inc.ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com. CONTACT: ICU Medical, Inc. Brian Bonnell, Chief Financial Officer (949) 366-2183ICR, Inc. John Mills, Managing Partner (646) 277-1254Source: ICU Medical, Inc.
This medical device company is a vital part of the backbone of hospital products utilized in the U.S. and around the world.